Skip to Main Content

Paper Details

The choice of negative control antisense oligonucleotides dramatically impacts downstream analysis depending on the cellular background.
BMC Genom Data
0
2021
BEC, BEC transcriptomes, BECs, LEC, LECs, cell types, human, lncRNA target, lncRNAs, long noncoding RNAs, lymphatic or blood vascular endothelial cells, targeted cell, targeted cell type, transcriptomes
Author NameAffiliation
Chung-Chau HonRIKEN Center for Integrative Medical Sciences
Chung-Chau HonRIKEN Center for Life Science Technologies
Jordan A RamilowskiRIKEN Center for Integrative Medical Sciences
Jordan A RamilowskiRIKEN Center for Life Science Technologies
Michihira TagamiRIKEN Center for Integrative Medical Sciences
Michihira TagamiRIKEN Center for Life Science Technologies
Michihira TagamiRIKEN Center for Integrative Medical Sciences
Michihira TagamiRIKEN Center for Life Science Technologies
Masayoshi ItohRIKEN Center for Life Science Technologies
Masayoshi ItohRIKEN Center for Life Science Technologies
Imad AbugessaisaRIKEN Center for Integrative Medical Sciences
Imad AbugessaisaRIKEN Center for Life Science Technologies
Akira HasegawaRIKEN Center for Integrative Medical Sciences
Akira HasegawaRIKEN Center for Life Science Technologies
Takeya KasukawaRIKEN Center for Integrative Medical Sciences
Takeya KasukawaRIKEN Center for Life Science Technologies
Takeya KasukawaRIKEN Center for Integrative Medical Sciences
Takeya KasukawaRIKEN Center for Life Science Technologies
Harukazu SuzukiRIKEN Center for Integrative Medical Sciences
Harukazu SuzukiRIKEN Center for Life Science Technologies
Harukazu SuzukiRIKEN Center for Integrative Medical Sciences
Harukazu SuzukiRIKEN Center for Life Science Technologies
Yoshihide HayashizakiRIKEN Center for Integrative Medical Sciences
Yoshihide Hayashizaki
Yoshihide HayashizakiRIKEN Center for Life Science Technologies
Yoshihide HayashizakiRIKEN Center for Integrative Medical Sciences
Yoshihide HayashizakiRIKEN Center for Life Science Technologies
Yoshihide Hayashizaki
Jay W ShinRIKEN Center for Integrative Medical Sciences
Jay W ShinRIKEN Center for Life Science Technologies
Dave S B HoonRIKEN Center for Integrative Medical Sciences
Dave S B HoonRIKEN Center for Life Science Technologies
Dave S B HoonRIKEN Center for Integrative Medical Sciences
Dave S B HoonRIKEN Center for Life Science Technologies
Michael DetmarInstitute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich
  • 1 - 35

Datasets

Release 1.2